Evaluation of the pharmacogenetics of immune recovery in treated HIV-infected patients-Reference-Cited by-同舟云学术

Evaluation of the pharmacogenetics of immune recovery in treated HIV-infected patients

Published:2013-11-21 Issue:1 Volume:10 Page:81-101
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Peraire Joaquim,Viladés Consuelo,Pacheco Yolanda M,López-Dupla Miguel,Domingo Pere,Gutiérrez Mar,Rosado Isaac,Leal Manuel,Richart Cristóbal,Vidal Francesc

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2014.854330

Reference123 articles.

1. Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions

2. Immunological recovery and antiretroviral therapy in HIV-1 infection

3. Determinants of CD4+T Cell Recovery during Suppressive Antiretroviral Therapy: Association of Immune Activation, T Cell Maturation Markers, and Cellular HIV‐1 DNA

4. The Pharmacogenetics of Antiretroviral Therapy: A Review of Studies to Date

5. Genetic factors that confer sensitivity to HAART in HIV-infected subjects: implication of a benefit of an earlier initiation of HAART

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of pyroptosis in incomplete immune reconstitution among people living with HIV：Potential therapeutic targets;Pharmacological Research;2023-11

2. Multi-omics in HIV: searching insights to understand immunological non-response in PLHIV;Frontiers in Immunology;2023-08-15

3. A complex system of chemokines may hold the key to optimal CD4+ T-cell recovery after antiretroviral therapy;eBioMedicine;2020-12

4. Genetics and immunological recovery with antiretroviral treatment for HIV;Pharmacogenomics;2020-09

5. CCR5 genotype and pre-treatment CD4+ T-cell count influence immunological recovery of HIV-positive patients during antiretroviral therapy;Gene;2020-05